Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Sarah Shuker

Physician Assistant Mesa, AZ Physician Assistant

NPI 1336769850 CMS profile 11218798

5424 E Southern Ave Ste 103, Mesa, AZ 85206

Open in the dashboard

General payments

$7,377

241 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Sarah Shuker of Mesa, AZ is reported in the CMS Open Payments database as having received $7,377 across 241 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,768 50
2024 General $1,782 57
2023 General $1,131 40
2022 General $1,745 64
2021 General $951 30

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sarah Shuker
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Sarah Shuker were reported at $1,768. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Sarah Shuker Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $951 $132 $37–$438 $132
2022 $1,745 $155 $48–$522 $149
2023 $1,131 $167 $52–$557 $160
2024 $1,782 $178 $55–$600 $164
2025 $1,768 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. LEO Pharma Inc. $1,330 46 payments
  2. Incyte Corporation $755 25 payments
  3. Arcutis Biotherapeutics, Inc. $634 24 payments
  4. Galderma Laboratories, L.P. $557 11 payments
  5. EPI Health, LLC $455 9 payments
  6. UCB, Inc. $431 11 payments
  7. Ortho Dermatologics, a division of Bausch Health US, LLC $374 18 payments
  8. AbbVie, Inc. $355 8 payments
  9. Regeneron Healthcare Solutions, Inc. $300 9 payments
  10. Dermavant Sciences, Inc. $251 7 payments
  11. Other $1,934 73 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $7,377 241 payments
Products named General payments · program years 2021–2025
  1. ADBRY $1,065 31 payments
  2. OPZELURA $755 25 payments
  3. Zoryve $634 24 payments
  4. RHOFADE $455 9 payments
  5. WYNZORA $455 9 payments
  6. MINOLIRA EXTENDED RELEASE Dermatology $455 9 payments
  7. MINOLIRA EXTENDED RELEASE Dermatology $455 9 payments
  8. CLODERM $455 9 payments
  9. Bimzelx $363 8 payments
  10. SKYRIZI $278 5 payments
  11. Other $5,294 184 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

241 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record